Serveur d'exploration Chloroquine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

S55 Pulmonary fibrosis with and without co-existing connective tissue disease: does it affect survival?

Identifieur interne : 001670 ( Main/Exploration ); précédent : 001669; suivant : 001671

S55 Pulmonary fibrosis with and without co-existing connective tissue disease: does it affect survival?

Auteurs : V. Navaratnam [Royaume-Uni] ; N. Ali [Royaume-Uni] ; Cjp Smith [Royaume-Uni] ; A. Fogarty [Royaume-Uni] ; R B Hubbard [Royaume-Uni]

Source :

RBID : ISTEX:E54E1CCF3E86C2BA39815DABEA296F43C57AAE13

English descriptors

Abstract

Introduction The impact of co-existing connective tissue disease on the survival of patients with pulmonary fibrosis remains unclear, since studies into the subject have so far yielded varying results. This study compares the survival of individuals with idiopathic pulmonary fibrosis (IPF) to those with connective tissue disease associated pulmonary fibrosis (CTD-PF) using data from The Health Improvement Network (THIN), a large general practice database in the UK. Methods Incident cases of individuals with IPF and CTD-PF between the years 2000 and 2008 were identified. Survival analysis was performed on this dataset using Kaplan–Meier methods and Cox regression was used to compare mortality rates between patients with IPF and CTD-PF, adjusting for age and gender. Results During the study period, there were 2208 incident cases of IPF, who were predominantly male (64%) and had a mean age at time of diagnosis of 73.9 years (95% CI 73.5 to 74.4 years). In comparison there were 318 incident cases of CTD-PF, of which the majority were female (56%) and the mean age at time of diagnosis was 67.8 years (95% CI 66.6 to 68.9). The commonest connective tissue disease associated with pulmonary fibrosis was rheumatoid arthritis (211 cases), followed by systemic sclerosis (39 cases). The mean follow-up period after diagnosis for our cohort was 2.4 person years and during this period 1117 (51%) patients with IPF and 116 (36%) patients with CTD-PF had died. The mortality rates for patients with IPF and CTD-PF were 221 (95% CI 208 to 234) and 121 (95% CI 101 to 146) deaths per 1000 person years respectively. The median survival for patients with CTD-PF was significantly higher at 6.5 years compared to 3.2 years in patients with IPF (p=0.0033) (See Abstract S55 Figure 1). After adjusting for age and gender, patients with IPF had a worse prognosis compared to those with CTD-PF (HR 1.32, 95% CI 1.08 to 1.60). Kaplan–Meier survival estimates. Conclusion Individuals who have CTD-PF have a better prognosis after diagnosis when compared to those with IPF. This may relate to the differing natural histories of the diseases and needs further investigation.

Url:
DOI: 10.1136/thx.2010.150938.6


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">S55 Pulmonary fibrosis with and without co-existing connective tissue disease: does it affect survival?</title>
<author>
<name sortKey="Navaratnam, V" sort="Navaratnam, V" uniqKey="Navaratnam V" first="V" last="Navaratnam">V. Navaratnam</name>
</author>
<author>
<name sortKey="Ali, N" sort="Ali, N" uniqKey="Ali N" first="N" last="Ali">N. Ali</name>
</author>
<author>
<name sortKey="Smith, Cjp" sort="Smith, Cjp" uniqKey="Smith C" first="Cjp" last="Smith">Cjp Smith</name>
</author>
<author>
<name sortKey="Fogarty, A" sort="Fogarty, A" uniqKey="Fogarty A" first="A" last="Fogarty">A. Fogarty</name>
</author>
<author>
<name sortKey="Hubbard, R B" sort="Hubbard, R B" uniqKey="Hubbard R" first="R B" last="Hubbard">R B Hubbard</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:E54E1CCF3E86C2BA39815DABEA296F43C57AAE13</idno>
<date when="2010" year="2010">2010</date>
<idno type="doi">10.1136/thx.2010.150938.6</idno>
<idno type="url">https://api.istex.fr/ark:/67375/NVC-LSXH1Q5D-0/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">002980</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">002980</idno>
<idno type="wicri:Area/Istex/Curation">002980</idno>
<idno type="wicri:Area/Istex/Checkpoint">000615</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000615</idno>
<idno type="wicri:doubleKey">0040-6376:2010:Navaratnam V:s:pulmonary:fibrosis</idno>
<idno type="wicri:Area/Main/Merge">001673</idno>
<idno type="wicri:Area/Main/Curation">001670</idno>
<idno type="wicri:Area/Main/Exploration">001670</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">S55 Pulmonary fibrosis with and without co-existing connective tissue disease: does it affect survival?</title>
<author>
<name sortKey="Navaratnam, V" sort="Navaratnam, V" uniqKey="Navaratnam V" first="V" last="Navaratnam">V. Navaratnam</name>
<affiliation wicri:level="4">
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Divisional of Epidemiology, University of Nottingham, Nottingham</wicri:regionArea>
<orgName type="university">Université de Nottingham</orgName>
<placeName>
<settlement type="city">Nottingham</settlement>
<region type="nation">Angleterre</region>
<region type="région" nuts="1">Nottinghamshire</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Ali, N" sort="Ali, N" uniqKey="Ali N" first="N" last="Ali">N. Ali</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Queens Medical Centre, Nottingham University Hospitals Trust, Nottingham</wicri:regionArea>
<wicri:noRegion>Nottingham</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Smith, Cjp" sort="Smith, Cjp" uniqKey="Smith C" first="Cjp" last="Smith">Cjp Smith</name>
<affiliation wicri:level="4">
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Divisional of Epidemiology, University of Nottingham, Nottingham</wicri:regionArea>
<orgName type="university">Université de Nottingham</orgName>
<placeName>
<settlement type="city">Nottingham</settlement>
<region type="nation">Angleterre</region>
<region type="région" nuts="1">Nottinghamshire</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Fogarty, A" sort="Fogarty, A" uniqKey="Fogarty A" first="A" last="Fogarty">A. Fogarty</name>
<affiliation wicri:level="4">
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Divisional of Epidemiology, University of Nottingham, Nottingham</wicri:regionArea>
<orgName type="university">Université de Nottingham</orgName>
<placeName>
<settlement type="city">Nottingham</settlement>
<region type="nation">Angleterre</region>
<region type="région" nuts="1">Nottinghamshire</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Hubbard, R B" sort="Hubbard, R B" uniqKey="Hubbard R" first="R B" last="Hubbard">R B Hubbard</name>
<affiliation wicri:level="4">
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Divisional of Epidemiology, University of Nottingham, Nottingham</wicri:regionArea>
<orgName type="university">Université de Nottingham</orgName>
<placeName>
<settlement type="city">Nottingham</settlement>
<region type="nation">Angleterre</region>
<region type="région" nuts="1">Nottinghamshire</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Thorax</title>
<title level="j" type="abbrev">Thorax</title>
<idno type="ISSN">0040-6376</idno>
<idno type="eISSN">1468-3296</idno>
<imprint>
<publisher>BMJ Publishing Group Ltd and British Thoracic Society</publisher>
<date type="published" when="2010-12">2010-12</date>
<biblScope unit="volume">65</biblScope>
<biblScope unit="issue">Suppl 4</biblScope>
<biblScope unit="page" from="A27">A27</biblScope>
</imprint>
<idno type="ISSN">0040-6376</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0040-6376</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="Teeft" xml:lang="en">
<term>1cjp smith</term>
<term>American population</term>
<term>Better prognosis</term>
<term>Brosis</term>
<term>Case notes</term>
<term>Central airway disease characterised</term>
<term>Chest radiographs</term>
<term>Clinical characteristics</term>
<term>Commonest treatment</term>
<term>Conclusion individuals</term>
<term>Connective tissue disease</term>
<term>Cutaneous involvement</term>
<term>Drive future hypothesisbased studies</term>
<term>Dynamic decrease</term>
<term>Exercise capacity</term>
<term>Flat trachea syndrome</term>
<term>Further investigation</term>
<term>Health improvement network</term>
<term>Incident cases</term>
<term>Intravenous methylprednisolone</term>
<term>Kaplanemeier methods</term>
<term>Kaplanemeier survival estimates</term>
<term>Large bronchi</term>
<term>Lung capacity</term>
<term>Median survival</term>
<term>Methods incident cases</term>
<term>Mortality rates</term>
<term>Natural histories</term>
<term>Neurological disease</term>
<term>Nodular lesions</term>
<term>Nottingham</term>
<term>Nottingham university hospitals trust</term>
<term>Novel registry</term>
<term>Obstructive airways disease</term>
<term>Other author</term>
<term>Other centres</term>
<term>Other organ involvement</term>
<term>Peculiar symptomology</term>
<term>Person years</term>
<term>Poor secretion management</term>
<term>Possible treatment option</term>
<term>Posterior tracheobronchial splinting</term>
<term>Potential patients</term>
<term>Practice database</term>
<term>Probable neurosarcoid</term>
<term>Prospective recording</term>
<term>Ptfe patch</term>
<term>Pulmonary disease</term>
<term>Pulmonary fibrosis</term>
<term>Random data quality checks</term>
<term>Recurrent infections</term>
<term>Retrospective pilot study</term>
<term>Retrospective series</term>
<term>Rheumatoid arthritis</term>
<term>Serum enzyme</term>
<term>Sessions extrapolation</term>
<term>Severe dyspnoea</term>
<term>Skin biopsy</term>
<term>Skin disease</term>
<term>Skin rashes</term>
<term>Study period</term>
<term>Survival analysis</term>
<term>Systemic sclerosis</term>
<term>Thorax december</term>
<term>Tissue disease</term>
<term>Trachea syndrome</term>
<term>Tracheal lumen</term>
<term>Uncontrollable cough</term>
<term>University hospital</term>
<term>Valuable method</term>
<term>Viith nerve palsy</term>
<term>Visual disturbance</term>
<term>Worse prognosis</term>
<term>Zajicek criteria</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract">Introduction The impact of co-existing connective tissue disease on the survival of patients with pulmonary fibrosis remains unclear, since studies into the subject have so far yielded varying results. This study compares the survival of individuals with idiopathic pulmonary fibrosis (IPF) to those with connective tissue disease associated pulmonary fibrosis (CTD-PF) using data from The Health Improvement Network (THIN), a large general practice database in the UK. Methods Incident cases of individuals with IPF and CTD-PF between the years 2000 and 2008 were identified. Survival analysis was performed on this dataset using Kaplan–Meier methods and Cox regression was used to compare mortality rates between patients with IPF and CTD-PF, adjusting for age and gender. Results During the study period, there were 2208 incident cases of IPF, who were predominantly male (64%) and had a mean age at time of diagnosis of 73.9 years (95% CI 73.5 to 74.4 years). In comparison there were 318 incident cases of CTD-PF, of which the majority were female (56%) and the mean age at time of diagnosis was 67.8 years (95% CI 66.6 to 68.9). The commonest connective tissue disease associated with pulmonary fibrosis was rheumatoid arthritis (211 cases), followed by systemic sclerosis (39 cases). The mean follow-up period after diagnosis for our cohort was 2.4 person years and during this period 1117 (51%) patients with IPF and 116 (36%) patients with CTD-PF had died. The mortality rates for patients with IPF and CTD-PF were 221 (95% CI 208 to 234) and 121 (95% CI 101 to 146) deaths per 1000 person years respectively. The median survival for patients with CTD-PF was significantly higher at 6.5 years compared to 3.2 years in patients with IPF (p=0.0033) (See Abstract S55 Figure 1). After adjusting for age and gender, patients with IPF had a worse prognosis compared to those with CTD-PF (HR 1.32, 95% CI 1.08 to 1.60). Kaplan–Meier survival estimates. Conclusion Individuals who have CTD-PF have a better prognosis after diagnosis when compared to those with IPF. This may relate to the differing natural histories of the diseases and needs further investigation.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Royaume-Uni</li>
</country>
<region>
<li>Angleterre</li>
<li>Nottinghamshire</li>
</region>
<settlement>
<li>Nottingham</li>
</settlement>
<orgName>
<li>Université de Nottingham</li>
</orgName>
</list>
<tree>
<country name="Royaume-Uni">
<region name="Angleterre">
<name sortKey="Navaratnam, V" sort="Navaratnam, V" uniqKey="Navaratnam V" first="V" last="Navaratnam">V. Navaratnam</name>
</region>
<name sortKey="Ali, N" sort="Ali, N" uniqKey="Ali N" first="N" last="Ali">N. Ali</name>
<name sortKey="Fogarty, A" sort="Fogarty, A" uniqKey="Fogarty A" first="A" last="Fogarty">A. Fogarty</name>
<name sortKey="Hubbard, R B" sort="Hubbard, R B" uniqKey="Hubbard R" first="R B" last="Hubbard">R B Hubbard</name>
<name sortKey="Smith, Cjp" sort="Smith, Cjp" uniqKey="Smith C" first="Cjp" last="Smith">Cjp Smith</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001670 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001670 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:E54E1CCF3E86C2BA39815DABEA296F43C57AAE13
   |texte=   S55 Pulmonary fibrosis with and without co-existing connective tissue disease: does it affect survival?
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021